We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




NHS Commits to Build Proton Therapy Devices

By HospiMedica International staff writers
Posted on 12 Aug 2013
The United Kingdom National Health Service (NHS; London) has laid plans to set aside GBP 250 million to build two proton beam therapy (PBT) systems for cancer, even as private companies explore similar ventures.

Currently, there are no PBT devices in the UK. More...
The NHS has instead established a program to send patients overseas (currently to the United States) for PBT, via a clinical panel that reviews individual cases referred for treatment and decides whether the case is suitable. About 100 patients each year are sent for treatment; but the treatment itself is not cheap, and can run into the hundreds of thousands of dollars.

The NHS option, once implemented, should reduce the costs to approximately USD 90,000 per patient. The reduced per patient cost and the availability of a local treatment option would enable the two PBT centers, which will be located in London and Manchester, to serve up to 1,500 patients, and will also results in lower costs for family members and reduced stress levels. Both centers should open by 2018.

“By investing in proton-beam therapy facilities, we will be able to treat more patients in the UK and reduce the stress placed on families who have had to travel to the United States to receive this innovative treatment,” said UK Public Health Minister Anna Soubry. “This is a huge milestone for the NHS – not only will Proton Beam Therapy help save more lives, it will also ensure that patients experience fewer side-effects and have a better quality of life.”

Alongside the NHS effort, the private sector is also investing in building PBT centers. One example is Advanced Proton Solutions (APS, London, UK), which has approval to construct one in central London. Other companies focused on PBT centers include Ion Beam Applications (Louvain-la-Neuve, Belgium), Hitachi (Tokyo, Japan), and Advanced Oncotherapy (London, UK), which will develop PBT centers in Birmingham, Manchester, and Scotland together with BMI Healthcare, a private-hospital operator owned by Apax Partners and Netcare.

PBT is a precise form of radiotherapy that uses charged particles instead of X-rays to deliver a dose of radiotherapy for patients. It can be a more effective form of treatment than conventional radiotherapy because it directs radiotherapy more precisely, with minimal damage to surrounding tissue. Evidence is growing that protons can be effective in treating a number of cancers, in particular children and young people with brain tumors, for whom PBT appears to produce fewer side effects such as secondary cancers, growth deformity, hearing loss, and learning difficulties.

Related Links:

United Kingdom National Health Service
Advanced Proton Solutions
Ion Beam Applications




Gold Member
12-Channel ECG
CM1200B
Biochip Array Technology
Evidence MultiSTAT Drugs of Abuse Urine Multiplex Panel
Syringe Pump
SP50 Series
Creatinine/eGFR Meter
StatSensor® Creatinine/eGFR Meter
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Sphere-9 is the first all-in-one mapping and ablation, large-tip focal, dual-energy catheter to be CE marked for ventricular ablation (Photo courtesy of Medtronic)

Dual-Energy Mapping and Ablation Catheter Receives CE Mark for Ventricular Arrhythmias

Ventricular arrhythmias, including ventricular tachycardia and premature ventricular complexes, can be life-threatening and often occur in patients with advanced heart disease. Although catheter ablation... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.